GlaxoSmithKline and Anacor Pharmaceuticals announced that they have entered into a worldwide strategic alliance for the discovery, development and commercialisation of novel medicines for viral and bacterial diseases. The collaboration provides GlaxoSmithKline access to Anacor’s proprietary boron-based chemistry for use against selected targets.
Researchers are now one step closer to improved treatment of Type 2 diabetes following significant findings made by scientists at the Garvan Institute of Medical Research.
Delivering the highest quality of care for all, as good or better than any country in the world, must be a fundamental goal of the NHS, said Lord Darzi, as he publishes his interim report on the ‘Our NHS, Our Future’ review.
Sanofi-aventis announced that the U.S. Food and Drug Administration (FDA) has approved Taxotere(R) (docetaxel) Injection Concentrate in combination with cisplatin and 5-fluorouracil for induction therapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN) before patients undergo chemoradiotherapy and surgery.
Novartis and the Massachusetts Institute of Technology have launched a long-term research collaboration aimed at transforming the way pharmaceuticals are produced. The 10-year partnership, known as the Novartis-MIT Center for Continuous Manufacturing, will work to develop new technologies that could replace the conventional batch-based system in the pharmaceuticals industry – which often includes many interruptions and work at separate sites – with continuous manufacturing processes from start to finish.
Participants at a United Nations-sponsored conference in Brussels have called for increased investment in vaccination, screening and treatment to eliminate cervical cancer, a preventable disease that kills 250,000 women annually – 80 per cent of them in developing countries.
Pills, sponges, IUDs, diaphragms– women have many options for planning their fertility, none of them quite perfect. But what if men want to help out? They have only two options — vasectomy, which is usually permanent, and condoms, which are crucial for dating but get old in long-term relationships. Will men ever have a way to reliably make sure that nobody is every calling them “Daddy” before they are ready?
GlaxoSmithKline (NYSE: GSK)announced that it will join with other pharmaceutical companies, academic institutions and the U.S. Food and Drug Administration to research genetic markers that may help predict who is at risk for serious drug-related adverse events.
The London School of Hygiene & Tropical Medicine is to be a key player in the first global research collaboration aimed at identifying the genetic markers related to Adverse Drug Reactions (ADRs).
Roche announced that the European Medicines Agency’s (EMEA) Committee for Human Medicinal Products (CHMP) has recommended that Viracept’s marketing authorization is re-instated in Europe following its suspension earlier this summer.